Prognosis Clinical Trials

14 recruiting

Prognosis Trials at a Glance

23 actively recruiting trials for prognosis are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Beijing, Shanghai, and Marseille. Lead sponsors running prognosis studies include Lei Li, Centre Hospitalier Universitaire, Amiens, and Beijing Friendship Hospital.

Browse prognosis trials by phase

Treatments under study

About Prognosis Clinical Trials

Looking for clinical trials for Prognosis? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Prognosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Prognosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 23 trials

Recruiting
Not Applicable

Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures

PrognosisCarcinoma, Pancreatic Ductal
Institut Curie85 enrolled7 locationsNCT05475366
Recruiting

Cardiac Magnetic Resonance-Clinical Prediction Model-Dilated Cardiomyopathy

Heart FailurePrognosisRisk Assessment+4 more
Shandong Provincial Hospital2,000 enrolled1 locationNCT07527715
Recruiting

Validation of RCC Predicting Model With Emulated-target Trial

Prognostic Cancer ModelRenal Cell Carcinoma (RCC)Prognosis+4 more
Peking University Third Hospital4,700 enrolled1 locationNCT07117227
Recruiting

Early Evaluation of Exosome Multiomics and Clinical Prognosis in Patients With Sudden Death

Sudden Cardiac DeathExosome MultiomicsClinical Prognosis
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School300 enrolled1 locationNCT06856993
Recruiting

Preoperative Serum FGF19 in the Prognosis of Biliary Atresia

PrognosisBiliary Atresia
Children's Hospital of Fudan University200 enrolled1 locationNCT05848310
Recruiting

Thrombus Composition in Ischemic Stroke: Analysis of the Correlation With Plasma Biomarkers, Efficacy of Treatment, Etiology and Prognosis

PrognosisBiomarkersStroke, Acute+2 more
Fondation Ophtalmologique Adolphe de Rothschild1,200 enrolled12 locationsNCT03268668
Recruiting

PBC Long-term Outcomes Study

PrognosisPrimary Biliary Cholangitis (PBC)Long-term Outcomes+1 more
Beijing Friendship Hospital4,000 enrolled1 locationNCT07149675
Recruiting
Not Applicable

Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients

MastectomyBreast NeoplasmsPain, Postoperative+4 more
Peking University First Hospital1,206 enrolled2 locationsNCT05494502
Recruiting

Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke

ThrombectomyStroke, IschemicMagnetic Resonance Imaging+4 more
Centre Hospitalier de Gonesse152 enrolled1 locationNCT07069452
Recruiting
Not Applicable

Effect of Bone Augmentation Simultaneous to Implant Removal on the Prognosis of Reimplantation at the Same Site

PrognosisBone AugmentationImplant Failure
The Dental Hospital of Zhejiang University School of Medicine40 enrolled3 locationsNCT07078890
Recruiting
Not Applicable

Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch

SmartwatchesThoracic SurgeryPostoperative Atrial Fibrillation+4 more
Centre Hospitalier Universitaire, Amiens302 enrolled1 locationNCT06724718
Recruiting

Predicting Ventilator-associated Lower Respiratory Tract Infection Outcomes Using Sequenced-based Early Microbiological Response

PrognosisRespiratory Tract InfectionsPneumonia, Ventilator-Associated
The First Affiliated Hospital with Nanjing Medical University200 enrolled1 locationNCT06467864
Recruiting

Association of Psychological Distress in Patients With Lung Cancer

Lung NeoplasmsPsychological DistressPrognosis Factors+1 more
Shanghai Chest Hospital500 enrolled1 locationNCT06218901
Recruiting
Not Applicable

Effect of the Postoperative Trendelenburg Position on Chronic Subdural Hematoma Recurrence

MortalityPrognosisRecurrence+3 more
Universidad de Antioquia254 enrolled3 locationsNCT06911736
Recruiting

Profiling the Intratumoral Microbiome of Pancreatic Ductal Adenocarcinoma Based on EUS-FNB Tissue Samples and Exploring Its Impact on Tumor Diagnosis and Prognosis.

Pancreatic CancerDiagnosisPrognosis+2 more
The Third Xiangya Hospital of Central South University50 enrolled1 locationNCT06655233
Recruiting

Exploratory Study on the Correlation Between HRD Score and PARPi Efficacy Based on Chinese Ovarian Cancer Patients

Exploring the Correlation of HRD Score Pairs with the Prognosis of Chinese Ovarian Cancer Patients and the Outcome of Maintenance Therapy with PARPi
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University470 enrolled1 locationNCT06622798
Recruiting

Evaluation of the Levels of Calcitonin Gene-related Peptide and Substance P

DiagnosisPrognosisMeningitis
Melike Cengiz51 enrolled1 locationNCT06510751
Recruiting

Lipoprotein a is an Independent Risk Factor for Overall Survival in Patients With Pancreatic Cancer: a Propensity Score Matching Analysis

Pancreatic Carcinoma; Lipoprotein a; Overall Survival; Prognosis
jingxue360 enrolled1 locationNCT06316466
Recruiting

ctDNA Methylation for Epithelial Ovarian Cancer

Circulating Tumor DNAEpithelial Ovarian CancerDNA Methylation+5 more
Lei Li5,000 enrolled1 locationNCT05801263
Recruiting

ctDNA Methylation for Detecting Ovarian Cancer

Circulating Tumor DNAEpithelial Ovarian CancerDNA Methylation+6 more
Lei Li1,400 enrolled1 locationNCT05801276